Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3851
John B. Sanfilippo & Son
JBSS
$666M
| $221K | ﹤0.01% |
3,323
+641
| +24% | +$50.1K |
2016 Q3
40 quarters
|
|
3852
Richmond Mutual Bancorp
RMBI
$253M
| $220K | ﹤0.01% |
14,795
+4,196
| +40% | +$65.5K |
2022 Q1
18 quarters
|
|
3853
State Street SPDR S&P Dividend ETF
SDY
$22.7B
| $220K | ﹤0.01% |
1,500
| – | – |
2026 Q1
2 quarters
|
|
3854
CoastalSouth Bancshares
COSO
$336M
| $220K | ﹤0.01% |
8,373
+580
| +7% | +$15.8K |
2025 Q3
4 quarters
|
|
3855
Puma Biotechnology
PBYI
$416M
| $219K | ﹤0.01% |
22,098
+10,896
| +97% | +$95.9K |
2016 Q3
40 quarters
|
|
3856
Seanergy Maritime Holdings
SHIP
$335M
| $219K | ﹤0.01% |
13,343
-2,065
| -13% | -$34.5K |
2022 Q1
18 quarters
|
|
3857
Palladyne AI
PDYN
$178M
| $218K | ﹤0.01% |
42,257
+30,198
| +250% | +$170K |
2022 Q1
18 quarters
|
|
3858
Quad
QUAD
$388M
| $218K | ﹤0.01% |
23,580
+19,245
| +444% | +$183K |
2016 Q1
42 quarters
|
|
3859
Copel
ELPC
$8.14B
| $217K | ﹤0.01% |
+17,474
| New | +$205K |
2026 Q3
0 quarters
|
|
3860
Silicom
SILC
$185M
| $217K | ﹤0.01% |
4,146
+1,184
| +40% | +$51.8K |
2015 Q2
45 quarters
|
|
3861
Shattuck Labs
STTK
$502M
| $216K | ﹤0.01% |
31,683
+14,309
| +82% | +$99.1K |
2026 Q1
2 quarters
|
|
3862
Immatics
IMTX
$1.03B
| $215K | ﹤0.01% |
24,535
-21,730
| -47% | -$200K |
2023 Q1
14 quarters
|
|
3863
Vanguard Real Estate ETF
VNQ
$38.8B
| $215K | ﹤0.01% |
2,400
-95
| -4% | -$9.2K |
2022 Q2
17 quarters
|
|
3864
RxSight
RXST
$213M
| $215K | ﹤0.01% |
43,849
+21,992
| +101% | +$129K |
2022 Q1
18 quarters
|
|
3865
Precision BioSciences
DTIL
$254M
| $214K | ﹤0.01% |
34,220
+22,898
| +202% | +$173K |
2019 Q2
29 quarters
|
|
3866
PUT
Kinder Morgan
KMI
$70.2B
| $214K | ﹤0.01% |
+7,100
| New | +$225K |
2026 Q3
0 quarters
|
|
3867
CALL
Burlington
BURL
$16B
| $214K | ﹤0.01% |
+800
| New | +$248K |
2026 Q3
0 quarters
|
|
3868
Tronox
TROX
$455M
| $213K | ﹤0.01% |
53,829
+2,895
| +6% | +$15.8K |
2013 Q4
51 quarters
|
|
3869
Farmland Partners
FPI
$374M
| $212K | ﹤0.01% |
18,692
+11,764
| +170% | +$119K |
2017 Q1
38 quarters
|
|
3870
FT Vest US Equity Enhance & Moderate Buffer ETF February
XFEB
$61.6M
| $212K | ﹤0.01% |
5,542
| – | – |
2024 Q3
8 quarters
|
|
3871
FT Vest US Equity Moderate Buffer ETF August
GAUG
$416M
| $212K | ﹤0.01% |
5,028
| – | – |
2024 Q3
8 quarters
|
|
3872
Abacus Global Management
ABX
$887M
| $211K | ﹤0.01% |
26,232
+1,721
| +7% | +$16.9K |
2025 Q1
6 quarters
|
|
3873
Avalyn Pharma
AVLN
$1.38B
| $211K | ﹤0.01% |
7,419
+3,029
| +69% | +$97.7K |
2026 Q2
1 quarter
|
|
3874
FT Vest US Equity Moderate Buffer ETF October
GOCT
$457M
| $211K | ﹤0.01% |
4,940
| – | – |
2024 Q3
8 quarters
|
|
3875
FT Vest US Equity Enhance & Moderate Buffer ETF July
XJUL
$41.8M
| $211K | ﹤0.01% |
5,053
| – | – |
2024 Q3
8 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.